Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

Five months after taking over the federal agency responsible for the health of all Americans, Robert F. Kennedy Jr. wants to overhaul an obscure but vital program that underpins the nation’s ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.

U.S. factories face job losses and uncertainty as tariffs rise, subsidies end, and manufacturers wait for clarity on trade policy and economic direction.

GSK's vaccine is currently approved in the U.S. for preventing RSV-related disease in adults aged 60 and above, and in at-risk adults aged 50 to 59.

A report new Intel CEO Lip-Bu Tan is considering costly changes to the company's chip manufacturing business rattled shares this week. Monitor these key chart levels.

This could be America’s future if Robert F. Kennedy Jr. continues his rampage against public health—and it may arrive much sooner than you think.

BOSTON — As turmoil engulfed a federal vaccine advisory panel earlier this month, Massachusetts Department of Public Health Commissioner Robbie Goldstein urged his own set of advisors to stay ...

Nike’s shares are rising sharply after saying it plans to shift some of its production away from China.

Nike’s shares jumped at the opening bell Friday after the company said it’s shifting some production away from China. But it also warned that tariffs imposed by the Trump administration… ...